Brookfield Health Dept. Update On J&J Vaccine Safety And Efficacy

Press release from Brookfield Health Department:

July 13, 2021 - 12:42pm

Recent reports have been circulating regarding the safety and efficacy of the Johnson & Johnson (Janssen) Vaccine. These reports concern a very rare condition called Guillain-Barre’ Syndrome, primarily affecting the Nervous System, as being associated with the J & J vaccine. This syndrome has also been reported as rarely associated with the Shingrix vaccine for Shingles and was reported as associates with the Swine Flu vaccine of 2009. Such reports are few and far between and are currently being studied by the CDC in more detail. However, the benefits of the COVID-19 vaccine from J & J still FAR outweigh the chances of being affected with Guillain- Barre’. The J & J vaccine has been proven useful against the newly-circulating and more highly contagious Delta variant of the virus as well. This variant has accounted for almost 80% of hospitalizations and serious illnesses, virtually all occurring in unvaccinated people.

The Health Department still encourages all residents 18 years of age and older who remain unvaccinated to take the single-dose vaccine as a safe alternative to the devastating effects of COVID-19.

This press release was produced by Brookfield Health Department. The views expressed here are the author’s own.